Cargando…

Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder

Depression and cognitive dysfunction share a common neuropathological platform. Abnormal neural plasticity in the frontolimbic circuits has been linked to changes in the expression of neurotrophic factors, including IGF-1. These changes may result in clinical abnormalities observed over the course o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levada, Oleg A., Troyan, Alexandra S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659027/ https://www.ncbi.nlm.nih.gov/pubmed/29093741 http://dx.doi.org/10.1186/s12991-017-0161-3

Ejemplares similares

The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy
por: Troyan, Alexandra S., et al.
Publicado: (2020)

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
por: Levada, Oleg A., et al.
Publicado: (2020)

Poststroke Depression Biomarkers: A Narrative Review
por: Levada, Oleg A., et al.
Publicado: (2018)

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study
por: Levada, Oleg A., et al.
Publicado: (2017)

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study
por: Levada, Oleg A., et al.
Publicado: (2016)

Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia
por: Arinami, Hiroshi, et al.
Publicado: (2023)

The Functional Anatomy of Psychomotor Disturbances in Major Depressive Disorder
por: Liberg, Benny, et al.
Publicado: (2015)

Role of insulin-like growth factor 1, sex and corticosteroid hormones in male major depressive disorder
por: Arinami, Hiroshi, et al.
Publicado: (2021)

Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
por: Dam, V. H., et al.
Publicado: (2021)

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová, Martina, et al.
Publicado: (2019)

Expected Emotional Usefulness and Emotional Preference in Individuals with Major Depressive Disorder
por: Yoon, Sunkyung, et al.
Publicado: (2016)

Brain insulin signaling and cognition: Possible links
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
por: Dam, Vibeke Høyrup, et al.
Publicado: (2022)

Emotional working memory in patients with major depressive disorder
por: Li, Mi, et al.
Publicado: (2018)

Emotion Differentiation in Current and Remitted Major Depressive Disorder
por: Thompson, Renee J., et al.
Publicado: (2021)

Influence of on emotions and behavior of adolescents with major depressive disorder
por: Lu, Heli, et al.
Publicado: (2023)

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
por: Gui, Si-Wen, et al.
Publicado: (2018)

Association Between Major Depressive Disorder and Sleep Disturbances Through Inflammation in Adolescents
por: Reddy, Abhishek, et al.
Publicado: (2020)

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
por: Wang, Min, et al.
Publicado: (2019)

Electroencephalographic findings in patients with major depressive disorder during cognitive or emotional tasks: a systematic review
por: de Freitas, Sabrina B., et al.
Publicado: (2016)

Psychosocial Dysfunction in Major Depressive Disorder—Rationale, Design, and Characteristics of the Cognitive and Emotional Recovery Training Program for Depression (CERT-D)
por: Knight, Matthew James, et al.
Publicado: (2017)

Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial
por: Kheirabadi, Gholam Reza, et al.
Publicado: (2020)

The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2
por: Cline, Brandon H, et al.
Publicado: (2012)

Insulin-like growth factor- I and factors affecting it in thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2015)

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder
por: Watanabe, Keita, et al.
Publicado: (2022)

The Role of Attention to Emotion in Recovery from Major Depressive Disorder
por: Thompson, Renee J., et al.
Publicado: (2013)

Major Depressive Disorder Alters Perception of Emotional Body Movements
por: Kaletsch, Morten, et al.
Publicado: (2014)

Meta-analysis of emotion recognition deficits in major depressive disorder
por: Dalili, M. N., et al.
Publicado: (2015)

Two possible mechanisms of ganciclovir for treatment of major depressive disorder
por: Itoh, Kazuhiro, et al.
Publicado: (2023)

Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2021)

Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction
por: Jiang, Jue, et al.
Publicado: (2015)

Social Cognition in Borderline Personality Disorder: Evidence for Disturbed Recognition of the Emotions, Thoughts, and Intentions of others
por: Preißler, Sandra, et al.
Publicado: (2010)

Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease
por: Salem, Linda, et al.
Publicado: (2016)

Impact of Major Depressive Disorder on Prediabetes by Impairing Insulin Sensitivity
por: Li, Li, et al.
Publicado: (2016)

Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance
por: Rickenlund, A., et al.
Publicado: (2010)

The Role of Cognitive Coping Mechanisms in the Psychotherapeutic Approach of the Major Depressive Disorder
por: PĂTRU, SILVIA, et al.
Publicado: (2022)

The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD)
por: Pieters, T., et al.
Publicado: (2022)

The Association between Emotional Stress, Sleep Disturbance, Depression, and Burning Mouth Syndrome
por: Rezazadeh, Fahimeh, et al.
Publicado: (2021)

Disturbance of Oligodendrocyte Function Plays a Key Role in the Pathogenesis of Schizophrenia and Major Depressive Disorder
por: Miyata, Shingo, et al.
Publicado: (2015)

Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders
por: Liu, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g22ncr6pvsc6os7m6ki3nc47mb